Ian Shakil Augmedix, Inc. (AUGX) insider trading activity

Ian Shakil is CHIEF STRATEGY OFFICER of Augmedix, Inc.. Currently has a direct ownership of 0 shares of AUGX, which is worth approximately $0. The most recent transaction as insider was on Oct 02, 2024, when has been sold 7,701 shares (Common Stock) at a price of $2.35 per share, resulting in proceeds of $18,097. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Ian Shakil Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 02 2024	SELL Sale (or disposition) back to the issuer	$18,097 $2.35 p/Share	7,701 Reduced 100.0%	0 Common Stock
Aug 15 2024	SELL Payment of exercise price or tax liability	$3,205 $2.27 p/Share	1,412 Reduced 12.33%	10,039 Common Stock
Aug 15 2024	SELL Payment of exercise price or tax liability	$3,205 $2.27 p/Share	1,412 Reduced 15.49%	7,701 Common Stock
Aug 15 2024	BUY Exercise of conversion of derivative security	-	3,750 Added 24.67%	11,451 Common Stock
Aug 15 2024	BUY Exercise of conversion of derivative security	-	3,750 Added 29.15%	9,113 Common Stock
May 15 2024	SELL Open market or private sale	$1,650 $1.19 p/Share	1,387 Reduced 20.55%	5,363 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	-	3,750 Added 35.71%	6,750 Common Stock
Apr 15 2024	SELL Open market or private sale	$1,900 $3.8 p/Share	500 Reduced 14.29%	3,000 Common Stock
Apr 15 2024	BUY Exercise of conversion of derivative security	$430 $0.86 p/Share	500 Added 12.5%	3,500 Common Stock
Apr 12 2024	SELL Open market or private sale	$74,658 $3.82 p/Share	19,544 Reduced 86.69%	3,000 Common Stock
Apr 12 2024	BUY Exercise of conversion of derivative security	$16,807 $0.86 p/Share	19,544 Added 46.44%	22,544 Common Stock
Apr 11 2024	SELL Open market or private sale	$97,377 $3.93 p/Share	24,778 Reduced 89.2%	3,000 Common Stock
Apr 11 2024	BUY Exercise of conversion of derivative security	$21,309 $0.86 p/Share	24,778 Added 47.15%	27,778 Common Stock
Apr 10 2024	SELL Open market or private sale	$141,127 $3.87 p/Share	36,467 Reduced 92.4%	3,000 Common Stock
Apr 10 2024	BUY Exercise of conversion of derivative security	$31,361 $0.86 p/Share	36,467 Added 48.02%	39,467 Common Stock
Apr 09 2024	SELL Open market or private sale	$130,583 $4.14 p/Share	31,542 Reduced 91.31%	3,000 Common Stock
Apr 09 2024	BUY Exercise of conversion of derivative security	$23,656 $0.75 p/Share	31,542 Added 47.73%	34,542 Common Stock
Apr 08 2024	SELL Open market or private sale	$149,986 $3.97 p/Share	37,780 Reduced 92.64%	3,000 Common Stock
Apr 08 2024	BUY Exercise of conversion of derivative security	$18,280 $0.64 p/Share	28,563 Added 41.19%	40,780 Common Stock
Apr 05 2024	SELL Open market or private sale	$207,089 $4.03 p/Share	51,387 Reduced 80.79%	12,217 Common Stock
Apr 04 2024	SELL Open market or private sale	$265,828 $4.15 p/Share	64,055 Reduced 66.96%	31,610 Common Stock
Apr 03 2024	SELL Open market or private sale	$188,673 $4.11 p/Share	45,906 Reduced 32.43%	95,665 Common Stock
Apr 02 2024	SELL Open market or private sale	$149,621 $3.89 p/Share	38,463 Reduced 21.36%	141,571 Common Stock
Apr 01 2024	SELL Open market or private sale	$233,552 $3.96 p/Share	58,978 Reduced 24.68%	180,034 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$32,861 $0.64 p/Share	51,346 Added 17.68%	239,012 Common Stock

Ian Shakil

CHIEF STRATEGY OFFICER

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUGX shares.

Notify only if

Value

Insider Trading

Get notified when an Augmedix, Inc. insider buys or sells AUGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Augmedix, Inc.

Track Activities on AUGX

Account